Atlas Trials

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

Clinical trial NCT05708677 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT05708677
Sponsor
Abeona Therapeutics, Inc
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
RDEB
Start date
2021-02-09
Primary completion
2036-02-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.